Gelesis Holdings share price logo

Gelesis Holdings

OTC: GLSHQ

Live

as on

Gelesis Holdings Stock Performance

as on July 7, 2026 at 3:54 am IST

  • $0.00

Gelesis Holdings share price movements today

Previous Close
-
Open
-
Volume
3.6K
Market Cap
$7.3K
52 Week Low - High
-

Gelesis Holdings Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Gelesis Holdings Stock Fundamentals & Key Indicators

Check Gelesis Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.3K

EPS (TTM)

-0.7015

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.98

PEG Ratio

-0.00

Return On Equity TTM

32.19%

Gelesis Holdings stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Gelesis Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Gelesis Holdings image
Gelesis Holdings
NA$7.3KNANA-6.95%0.00%

Gelesis Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Total Revenue
3
2
3
2
7
8
6
2
1
1
Gross Profit
0
0
0
0
2
4
3
-11
0
0
Operating Income
-16
-19
-28
-20
-43
-34
-17
-26
-11
-9
EBITDA
-17
-23
-29
-17
-3
-11
-12
-20
-1
-5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
1
1
0
1
1
2
2
Income Before Tax
-18
-24
-30
-19
-5
-12
-14
-22
-5
-7
Income Tax Expense
0
-
-
-
-
-
-
0
0
-
Net Income
-18
-24
-30
-19
-5
-12
-14
-24
-5
-7
Net Profit Margin
9.19%
7.94%
8.33%
17.05%
34.62%
46.66%
45.64%
-441.97%
29.44%
55.01%

Gelesis Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Total Revenue
-
11
25
Gross Profit
-
1
-1
Operating Income
-
-84
-121
EBITDA
-12
-88
-48
Interest Expense
-
1
0
Depreciation
2
3
5
Income Before Tax
-15
-93
-55
Income Tax Expense
-
0
0
Net Income
-15
-93
-57
Net Profit Margin
0.00%
10.75%
-6.95%

Gelesis Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Net Income
-18
-24
-30
-19
-5
-12
-14
-23
-5
-7
Operating Cash Flow
-8
-27
8
-28
-35
-4
-21
-16
-8
0
Investing Cash Flow
17
-3
-8
-1
-1
-3
-3
0
0
0
Financing Cash Flow
3
0
1
27
42
0
24
0
4
4
Change in Cash
11
-29
1
-3
5
-8
0
-17
-4
4

Gelesis Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Net Income
-15
-93
-55
Operating Cash Flow
0
-55
-77
Investing Cash Flow
-276
4
-9
Financing Cash Flow
277
32
66
Change in Cash
0
-19
-20

About Gelesis Holdings

Gelesis Holdings, Inc. operated as a commercial-stage biotherapeutics company, concentrating on the development of biomimetic solutions. Its core mission revolved around addressing the root causes of obesity and various chronic gastrointestinal ailments. Among its offerings was PLENITY, an orally administered, non-stimulant, and non-systemic product designed to assist with weight management. The company's pipeline also included several other promising developments: GS200, targeting weight reduction for individuals with prediabetes and type 2 diabetes; and GS500, intended for the treatment of functional constipation. Furthermore, Gelesis had a pre-clinical stage product, GS300, in development for conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Founded in Boston, Massachusetts, in 2006, the company established its headquarters there. Regrettably, on October 30, 2023, Gelesis Holdings, Inc., alongside its affiliates, formally initiated voluntary Chapter 7 liquidation proceedings in the U.S. Bankruptcy Court for the District of Delaware.
OrganisationGelesis Holdings
Headquarters501 Boylston Street, Boston, MA, 02116, US
IndustryBiotechnology
CEOAlessandro Sannino

Key Management of Gelesis Holdings

Name

Title

Dr. Alessandro Sannino Ph.D.

Co-Inventor & Lead Project Scientist

Ms. Joy Bauer M.S., RDN

Chief Nutrition Officer of Plenity

FAQs

What is Gelesis Holdings's market capitalisation today?

Gelesis Holdings market capitalisation is $0.00T as on .

How to invest in Gelesis Holdings Stock (GLSHQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gelesis Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Gelesis Holdings Stock (GLSHQ) from India?

Indian investors can start investing in Gelesis Holdings (GLSHQ) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Gelesis Holdings stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .